-
24 Oct 2026
Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial
Nature Medicine
- Views 45
- More stats
-
24 Oct 2026
Engineering of Redox‐Active Residues Enhances P450 Peroxygenase Performance
Angewandte Chemie Int Ed
- Views 45
- More stats
-
29 Oct 2026
Syncope
The New England Journal of Medicine
- Views 45
- More stats
-
20 Oct 2026
Downsizing Electrophilic MAX‐Derived Helical Zipper Peptides to Covalently Bind and Degrade Oncogenic MYC
Angewandte Chemie Int Ed
- Views 45
- More stats
-
28 Oct 2026
Virtual sustained counseling, tobacco treatment improve quit rates in community oncology settings
CA: A Cancer Journal for Clinicians
- Views 45
- More stats
-
20 Oct 2026
The landscape of gene loss and missense variation across the mammalian tree informs on gene essentiality
Nature Genetics
- Views 45
- More stats
-
19 Oct 2026
RNA ends connect genetic risk to brain disease
Nature Genetics
- Views 45
- More stats
-
05 Nov 2026
Durability of Gene Therapy in Patients with Crigler–Najjar Syndrome
The New England Journal of Medicine
- Views 45
- More stats
-
27 Oct 2026
[Comment] Iberdomide for minimal residual disease-negative myeloma—from underdog to the spotlight
The Lancet Oncology
- Views 45
- More stats
-
01 Nov 2026
Janus Nanoporous Metal–Phenolic Nanosheet Membranes for Highly Efficient Osmotic Energy Harvesting
Angewandte Chemie Int Ed
- Views 45
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement